Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Clinical trial NCT00458913 · COMPLETED
Trial details
- NCT number
- NCT00458913
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2010-04-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.